Ovarian Cancer

>

Latest News

Ovarian Cancer Trials Expand Research Across Subtypes
Ovarian Cancer Trials Expand Research Across Subtypes

August 30th 2023

In an interview Targeted Oncology, Christina Fotopoulou, MD, PhD, discussed the background and results of 3 studies for patients with ovarian cancer.

Phase 3 Trial of TTFields and Paclitaxel Misses OS End Point in Ovarian Cancer
Phase 3 Trial of TTFields and Paclitaxel Misses OS End Point in Ovarian Cancer

August 28th 2023

Improving Outcomes in All Ovarian Cancer Subtypes
Improving Outcomes in All Ovarian Cancer Subtypes

August 4th 2023

Batiraxcept Fails to Improve PFS in Platinum-Resistant Ovarian Cancer
Batiraxcept Fails to Improve PFS in Platinum-Resistant Ovarian Cancer

August 4th 2023

Upifitamab Rilsodotin Misses Primary End Point in Ovarian Cancer
Upifitamab Rilsodotin Misses Primary End Point in Ovarian Cancer

August 2nd 2023

Video Series
Video Interviews

More News